New trial (S1802) for treatment of men with newly diagnosed, metastatic prostate cancer

Earlier this month we had mentioned hearing about a new trial to explore whether local ablation of the primary tumor could improve the outcomes of men initially diagnosed with metastatic prostate cancer. … READ MORE …

But annual, mass, population-based PSA screening really works (or does it?)

A new and potentially controversial article in Urology (the “Gold Journal”) has just suggested that regular, mass, population-based screening of men for risk of prostate cancer every 12 to 18 months remains a good idea. … READ MORE …

Hypothetical cost savings associated with “observation” for low-risk prostate cancer

A newly published article in JAMA Oncology has reported hypothetical costs savings to Medicare of $320 million over a 3-year time frame if men of > 70 years with low-risk prostate cancer are simply “observed” as opposed being given immediate treated. … READ MORE …

What prostate cancer awareness means to Dr. Alicia Morgans

Alicia Morgans, MD, MPH, is a medical oncologist who specializes in prostate cancer management at Northwestern University Feinberg School of Medicine in Chicago, Illinois, where she is an associate professor in the Division of Hematology/Oncology. She is also an editor of the Advanced Prostate Cancer Center of Excellence for the UroToday web site. … READ MORE …

“Prostate Cancer Today” — Dr. Frans Debruyne joins meeting faculty

This will be our last reminder that Prostate Cancer International is holding its second annual prostate cancer patient meeting (“Prostate Cancer Today: Living Well; Choosing Wisely”) on October 13, 2018, in Virginia Beach, near Norfolk, Virginia, USA. As of this morning we have > 170 advance registrants for this meeting. … READ MORE …

ASCO endorses AUA/ASTRO/SUO guidelines on treatment of localized prostate cancer

We are delighted to note that the American Society of Clinical Oncology (ASCO) has now endorsed 66 of the 68 guidelines issued in April 2017 on the treatment of localized prostate cancer by a joint working group from the American Uriological Association (AUA), the American Society of Radiation Oncology (ASTRO), and the Society for Urologic Oncology (SUO). … READ MORE …

Gallium-68 PET/CT scans prior to first-line treatment of some men with prostate cancer

A newly-reported set of data from an Australian clinical research team has now shown that 68Ga PSMA PET/CT scans changed the staging and the management of men after initial diagnosis and prior to first-line treatment compared to traditional CT and bone scanning. … READ MORE …